Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Table of Contents

CCR Translations

  • CCR Translations
    Inhibiting the Hypoxia Response for Cancer Therapy: The New Kid on the Block
    Mei Yee Koh, Taly R. Spivak-Kroizman and Garth Powis
    Clin Cancer Res October 1 2009 15 (19) 5945-5946; DOI:10.1158/1078-0432.CCR-09-1650

  • CCR Translations
    Rapid Development of Hypertension by Sorafenib: Toxicity or Target?
    Benjamin D. Humphreys and Michael B. Atkins
    Clin Cancer Res October 1 2009 15 (19) 5947-5949; DOI:10.1158/1078-0432.CCR-09-1717

Statistics in Clinical Cancer Research

  • Statistics in Clinical Cancer Research
    A Comparison of Phase II Study Strategies
    Sally Hunsberger, Yingdong Zhao and Richard Simon
    Clin Cancer Res October 1 2009 15 (19) 5950-5955; DOI:10.1158/1078-0432.CCR-08-3205

Molecular Pathways

  • Molecular Pathways
    Disrupting Polyamine Homeostasis as a Therapeutic Strategy for Neuroblastoma
    Nicholas F. Evageliou and Michael D. Hogarty
    Clin Cancer Res October 1 2009 15 (19) 5956-5961; DOI:10.1158/1078-0432.CCR-08-3213

  • Molecular Pathways
    On Trk—The TrkB Signal Transduction Pathway Is an Increasingly Important Target in Cancer Biology
    Carol J. Thiele, Zhijie Li and Amy E. McKee
    Clin Cancer Res October 1 2009 15 (19) 5962-5967; DOI:10.1158/1078-0432.CCR-08-0651

Human Cancer Biology

  • Human Cancer Biology
    CXCL13 and CXCL12 in Central Nervous System Lymphoma Patients
    Lars Fischer, Agnieszka Korfel, Sebastian Pfeiffer, Philipp Kiewe, Hans-Dieter Volk, Hüsniye Cakiroglu, Thomas Widmann and Eckhard Thiel
    Clin Cancer Res October 1 2009 15 (19) 5968-5973; DOI:10.1158/1078-0432.CCR-09-0108

  • Human Cancer Biology
    Nuclear NF-κB p65 Phosphorylation at Serine 276 by Protein Kinase A Contributes to the Malignant Phenotype of Head and Neck Cancer
    Pattatheyil Arun, Matthew S. Brown, Reza Ehsanian, Zhong Chen and Carter Van Waes
    Clin Cancer Res October 1 2009 15 (19) 5974-5984; DOI:10.1158/1078-0432.CCR-09-1352

  • Human Cancer Biology
    Loss of Heterozygosity at 2q37 in Sporadic Wilms' Tumor: Putative Role for miR-562
    Kylie M. Drake, E. Cristy Ruteshouser, Rachael Natrajan, Phyllis Harbor, Jenny Wegert, Manfred Gessler, Kathy Pritchard-Jones, Paul Grundy, Jeffrey Dome, Vicki Huff, Chris Jones and Micheala A. Aldred
    Clin Cancer Res October 1 2009 15 (19) 5985-5992; DOI:10.1158/1078-0432.CCR-09-1065

  • Human Cancer Biology
    Down-regulation of ZIP4 by RNA Interference Inhibits Pancreatic Cancer Growth and Increases the Survival of Nude Mice with Pancreatic Cancer Xenografts
    Min Li, Yuqing Zhang, Uddalak Bharadwaj, Qihui (Jim) Zhai, Charlotte H. Ahern, William E. Fisher, F. Charles Brunicardi, Craig D. Logsdon, Changyi Chen and Qizhi Yao
    Clin Cancer Res October 1 2009 15 (19) 5993-6001; DOI:10.1158/1078-0432.CCR-09-0557

  • Human Cancer Biology
    IDH1 Mutations as Molecular Signature and Predictive Factor of Secondary Glioblastomas
    Sumihito Nobusawa, Takuya Watanabe, Paul Kleihues and Hiroko Ohgaki
    Clin Cancer Res October 1 2009 15 (19) 6002-6007; DOI:10.1158/1078-0432.CCR-09-0715

  • Human Cancer Biology
    Spectrum of Phosphatidylinositol 3-Kinase Pathway Gene Alterations in Bladder Cancer
    Fiona M. Platt, Carolyn D. Hurst, Claire F. Taylor, Walter M. Gregory, Patricia Harnden and Margaret A. Knowles
    Clin Cancer Res October 1 2009 15 (19) 6008-6017; DOI:10.1158/1078-0432.CCR-09-0898

  • Human Cancer Biology
    Proinflammatory Mediators Upregulate Snail in Head and Neck Squamous Cell Carcinoma
    Maie A. St. John, Mariam Dohadwala, Jie Luo, Guanyu Wang, Gina Lee, Hubert Shih, Eileen Heinrich, Kostantyn Krysan, Tonya Walser, Saswati Hazra, Li Zhu, Chi Lai, Elliot Abemayor, Michael Fishbein, David A. Elashoff, Sherven Sharma and Steven M. Dubinett
    Clin Cancer Res October 1 2009 15 (19) 6018-6027; DOI:10.1158/1078-0432.CCR-09-0011

  • Human Cancer Biology
    Local Biosynthesis of Estrogen in Human Endometrial Carcinoma through Tumor-Stromal Cell Interactions
    Naomi Takahashi-Shiga, Hiroki Utsunomiya, Yasuhiro Miki, Satoru Nagase, Rika Kobayashi, Mitsuyo Matsumoto, Hitoshi Niikura, Kiyoshi Ito and Nobuo Yaegashi
    Clin Cancer Res October 1 2009 15 (19) 6028-6034; DOI:10.1158/1078-0432.CCR-09-1013

Cancer Therapy: Preclinical

  • Cancer Therapy: Preclinical
    Src Tyrosine Kinase Regulates Adhesion and Chemotaxis in Waldenstrom Macroglobulinemia
    Hai T. Ngo, Abdel Kareem Azab, Mena Farag, Xiaoying Jia, Molly M. Melhem, Judith Runnels, Aldo M. Roccaro, Feda Azab, Antonio Sacco, Xavier Leleu, Kenneth C. Anderson and Irene M. Ghobrial
    Clin Cancer Res October 1 2009 15 (19) 6035-6041; DOI:10.1158/1078-0432.CCR-09-0718

  • Cancer Therapy: Preclinical
    Antibody-Mediated Inhibition of Cathepsin S Blocks Colorectal Tumor Invasion and Angiogenesis
    Roberta E. Burden, Julie A. Gormley, Thomas J. Jaquin, Donna M. Small, Derek J. Quinn, Shauna M. Hegarty, Claire Ward, Brian Walker, James A. Johnston, Shane A. Olwill and Christopher J. Scott
    Clin Cancer Res October 1 2009 15 (19) 6042-6051; DOI:10.1158/1078-0432.CCR-09-1262

  • Cancer Therapy: Preclinical
    CEACAM5-Targeted Therapy of Human Colonic and Pancreatic Cancer Xenografts with Potent Labetuzumab-SN-38 Immunoconjugates
    Serengulam V. Govindan, Thomas M. Cardillo, Sung-Ju Moon, Hans J. Hansen and David M. Goldenberg
    Clin Cancer Res October 1 2009 15 (19) 6052-6061; DOI:10.1158/1078-0432.CCR-09-0586

  • Cancer Therapy: Preclinical
    Interaction of the Multikinase Inhibitors Sorafenib and Sunitinib with Solute Carriers and ATP-Binding Cassette Transporters
    Shuiying Hu, Zhaoyuan Chen, Ryan Franke, Shelley Orwick, Ming Zhao, Michelle A. Rudek, Alex Sparreboom and Sharyn D. Baker
    Clin Cancer Res October 1 2009 15 (19) 6062-6069; DOI:10.1158/1078-0432.CCR-09-0048

  • Cancer Therapy: Preclinical
    High-Throughput Cell-Based Screening of 4910 Known Drugs and Drug-like Small Molecules Identifies Disulfiram as an Inhibitor of Prostate Cancer Cell Growth
    Kristiina Iljin, Kirsi Ketola, Paula Vainio, Pasi Halonen, Pekka Kohonen, Vidal Fey, Roland C. Grafström, Merja Perälä and Olli Kallioniemi
    Clin Cancer Res October 1 2009 15 (19) 6070-6078; DOI:10.1158/1078-0432.CCR-09-1035

  • Cancer Therapy: Preclinical
    Targeted Radioiodine Therapy of Neuroblastoma Tumors following Systemic Nonviral Delivery of the Sodium Iodide Symporter Gene
    Kathrin Klutz, Verena Russ, Michael J. Willhauck, Nathalie Wunderlich, Christian Zach, Franz Josef Gildehaus, Burkhard Göke, Ernst Wagner, Manfred Ogris and Christine Spitzweg
    Clin Cancer Res October 1 2009 15 (19) 6079-6086; DOI:10.1158/1078-0432.CCR-09-0851

  • Cancer Therapy: Preclinical
    Blockade of MGMT Expression by O6 Benzyl Guanine Leads to Inhibition of Pancreatic Cancer Growth and Induction of Apoptosis
    Santhi D. Konduri, Jonathan Ticku, George C. Bobustuc, Robert M. Sutphin, Jimmie Colon, Beth Isley, Kishor K. Bhakat, Srivenugopal S. Kalkunte and Cheryl H. Baker
    Clin Cancer Res October 1 2009 15 (19) 6087-6095; DOI:10.1158/1078-0432.CCR-09-0887

  • Cancer Therapy: Preclinical
    Combined Bcl-2/Mammalian Target of Rapamycin Inhibition Leads to Enhanced Radiosensitization via Induction of Apoptosis and Autophagy in Non–Small Cell Lung Tumor Xenograft Model
    Kwang Woon Kim, Luigi Moretti, Lauren Rhea Mitchell, Dae Kwang Jung and Bo Lu
    Clin Cancer Res October 1 2009 15 (19) 6096-6105; DOI:10.1158/1078-0432.CCR-09-0589

  • Cancer Therapy: Preclinical
    Vasoactivity of AG014699, a Clinically Active Small Molecule Inhibitor of Poly(ADP-ribose) Polymerase: a Contributory Factor to Chemopotentiation In vivo?
    Majid Ali, Brian A. Telfer, Cian McCrudden, Martin O'Rourke, Huw D. Thomas, Marzieh Kamjoo, Suzanne Kyle, Tracy Robson, Chris Shaw, David G. Hirst, Nicola J. Curtin and Kaye J. Williams
    Clin Cancer Res October 1 2009 15 (19) 6106-6112; DOI:10.1158/1078-0432.CCR-09-0398

  • Cancer Therapy: Preclinical
    Antiglioma Immunological Memory in Response to Conditional Cytotoxic/Immune-Stimulatory Gene Therapy: Humoral and Cellular Immunity Lead to Tumor Regression
    A.K.M. Ghulam Muhammad, Marianela Candolfi, Gwendalyn D. King, Kader Yagiz, David Foulad, Yohei Mineharu, Kurt M. Kroeger, Katherine A. Treuer, W. Stephen Nichols, Nicholas S. Sanderson, Jieping Yang, Maksim Khayznikov, Nico Van Rooijen, Pedro R. Lowenstein and Maria G. Castro
    Clin Cancer Res October 1 2009 15 (19) 6113-6127; DOI:10.1158/1078-0432.CCR-09-1087

  • Cancer Therapy: Preclinical
    Identification of a Novel Small Molecule HIF-1α Translation Inhibitor
    Takuhito Narita, Shaoman Yin, Christine F. Gelin, Carlos S. Moreno, Manuel Yepes, K.C. Nicolaou and Erwin G. Van Meir
    Clin Cancer Res October 1 2009 15 (19) 6128-6136; DOI:10.1158/1078-0432.CCR-08-3180

  • Cancer Therapy: Preclinical
    A Novel Reduced Immunogenicity Bispecific Targeted Toxin Simultaneously Recognizing Human Epidermal Growth Factor and Interleukin-4 Receptors in a Mouse Model of Metastatic Breast Carcinoma
    Seunguk Oh, Brad J. Stish, Deepali Sachdev, Hua Chen, Arkadiusz Z. Dudek and Daniel A. Vallera
    Clin Cancer Res October 1 2009 15 (19) 6137-6147; DOI:10.1158/1078-0432.CCR-09-0696

  • Cancer Therapy: Preclinical
    Vorinostat Inhibits Brain Metastatic Colonization in a Model of Triple-Negative Breast Cancer and Induces DNA Double-Strand Breaks
    Diane Palmieri, Paul R. Lockman, Fancy C. Thomas, Emily Hua, Jeanne Herring, Elizabeth Hargrave, Matthew Johnson, Natasha Flores, Yongzhen Qian, Eleazar Vega-Valle, Kunal S. Taskar, Vinay Rudraraju, Rajendar K. Mittapalli, Julie A. Gaasch, Kaci A. Bohn, Helen R. Thorsheim, David J. Liewehr, Sean Davis, John F. Reilly, Robert Walker, Julie L. Bronder, Lionel Feigenbaum, Seth M. Steinberg, Kevin Camphausen, Paul S. Meltzer, Victoria M. Richon, Quentin R. Smith and Patricia S. Steeg
    Clin Cancer Res October 1 2009 15 (19) 6148-6157; DOI:10.1158/1078-0432.CCR-09-1039

  • Cancer Therapy: Preclinical
    Synergistic Effects of Oncolytic Reovirus and Cisplatin Chemotherapy in Murine Malignant Melanoma
    Hardev S. Pandha, Lucy Heinemann, Guy R. Simpson, Alan Melcher, Robin Prestwich, Fiona Errington, Matt Coffey, Kevin J. Harrington and Richard Morgan
    Clin Cancer Res October 1 2009 15 (19) 6158-6166; DOI:10.1158/1078-0432.CCR-09-0796

  • Cancer Therapy: Preclinical
    Lymph Node–Targeted Immunotherapy Mediates Potent Immunity Resulting in Regression of Isolated or Metastatic Human Papillomavirus–Transformed Tumors
    Kent A. Smith, Brenna L. Meisenburg, Victor L. Tam, Robb R. Pagarigan, Raymond Wong, Diljeet K. Joea, Liz Lantzy, Mayra A. Carrillo, Todd M. Gross, Uriel M. Malyankar, Chih-Sheng Chiang, Diane M. Da Silva, Thomas M. Kündig, W. Martin Kast, Zhiyong Qiu and Adrian Bot
    Clin Cancer Res October 1 2009 15 (19) 6167-6176; DOI:10.1158/1078-0432.CCR-09-0645

  • Cancer Therapy: Preclinical
    Translocator Protein Blockade Reduces Prostate Tumor Growth
    Arlee Fafalios, Ardavan Akhavan, Anil V. Parwani, Robert R. Bies, Kevin J. McHugh and Beth R. Pflug
    Clin Cancer Res October 1 2009 15 (19) 6177-6184; DOI:10.1158/1078-0432.CCR-09-0844

Imaging, Diagnosis, Prognosis

  • Imaging, Diagnosis, Prognosis
    Aberrant Methylation of APC, MGMT, RASSF2A, and Wif-1 Genes in Plasma as a Biomarker for Early Detection of Colorectal Cancer
    Bo Bin Lee, Eun Ju Lee, Eun Hyun Jung, Ho-Kyung Chun, Dong Kyoung Chang, Sang Yong Song, Joobae Park and Duk-Hwan Kim
    Clin Cancer Res October 1 2009 15 (19) 6185-6191; DOI:10.1158/1078-0432.CCR-09-0111

  • Imaging, Diagnosis, Prognosis
    MicroRNA Expression in Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus: Associations with Survival
    Ewy A. Mathé, Giang Huong Nguyen, Elise D. Bowman, Yiqiang Zhao, Anuradha Budhu, Aaron J. Schetter, Rosemary Braun, Mark Reimers, Kensuke Kumamoto, Duncan Hughes, Nasser K. Altorki, Alan G. Casson, Chang-Gong Liu, Xin Wei Wang, Nozomu Yanaihara, Nobutoshi Hagiwara, Andrew J. Dannenberg, Masao Miyashita, Carlo M. Croce and Curtis C. Harris
    Clin Cancer Res October 1 2009 15 (19) 6192-6200; DOI:10.1158/1078-0432.CCR-09-1467

  • Imaging, Diagnosis, Prognosis
    Interstitial Fluid Pressure as a Prognostic Factor in Cervical Cancer Following Radiation Therapy
    Seung-Gu Yeo, Jun-Sang Kim, Moon-June Cho, Ki-Hwan Kim and Jae-Sung Kim
    Clin Cancer Res October 1 2009 15 (19) 6201-6207; DOI:10.1158/1078-0432.CCR-09-0560

  • Imaging, Diagnosis, Prognosis
    Associations of a Polymorphism in the Ornithine Decarboxylase Gene with Colorectal Cancer Survival
    Jason A. Zell, Argyrios Ziogas, Natalia Ignatenko, Jane Honda, Ning Qu, Alexander S. Bobbs, Susan L. Neuhausen, Eugene W. Gerner and Hoda Anton-Culver
    Clin Cancer Res October 1 2009 15 (19) 6208-6216; DOI:10.1158/1078-0432.CCR-09-0592

Cancer Therapy: Clinical

  • Cancer Therapy: Clinical
    A Phase II Study of SGN-30 in Cutaneous Anaplastic Large Cell Lymphoma and Related Lymphoproliferative Disorders
    Madeleine Duvic, Sunil A. Reddy, Lauren Pinter-Brown, Neil J. Korman, John Zic, Dana A. Kennedy, Jennie Lorenz, Eric L. Sievers and Youn H. Kim
    Clin Cancer Res October 1 2009 15 (19) 6217-6224; DOI:10.1158/1078-0432.CCR-09-0162

  • Cancer Therapy: Clinical
    A Phase I Pharmacokinetic and Biological Correlative Study of IMP321, a Novel MHC Class II Agonist, in Patients with Advanced Renal Cell Carcinoma
    Chrystelle Brignone, Bernard Escudier, Caroline Grygar, Manon Marcu and Frédéric Triebel
    Clin Cancer Res October 1 2009 15 (19) 6225-6231; DOI:10.1158/1078-0432.CCR-09-0068

  • Cancer Therapy: Clinical
    Phase I Dose-Escalation and Pharmacokinetic Study of Dasatinib in Patients with Advanced Solid Tumors
    George D. Demetri, Patricia Lo Russo, Iain R.J. MacPherson, Ding Wang, Jeffrey A. Morgan, Valerie G. Brunton, Prashni Paliwal, Shruti Agrawal, Maurizio Voi and T.R. Jeffry Evans
    Clin Cancer Res October 1 2009 15 (19) 6232-6240; DOI:10.1158/1078-0432.CCR-09-0224

  • Cancer Therapy: Clinical
    A Phase I Dose-Finding Study of 5-Azacytidine in Combination with Sodium Phenylbutyrate in Patients with Refractory Solid Tumors
    Jianqing Lin, Jill Gilbert, Michelle A. Rudek, James A. Zwiebel, Steve Gore, Anchalee Jiemjit, Ming Zhao, Sharyn D. Baker, Richard F. Ambinder, James G. Herman, Ross C. Donehower and Michael A. Carducci
    Clin Cancer Res October 1 2009 15 (19) 6241-6249; DOI:10.1158/1078-0432.CCR-09-0567

  • Cancer Therapy: Clinical
    Ambulatory Monitoring Detects Sorafenib-Induced Blood Pressure Elevations on the First Day of Treatment
    Michael L. Maitland, Kristen E. Kasza, Theodore Karrison, Kristin Moshier, Laura Sit, Henry R. Black, Samir D. Undevia, Walter M. Stadler, William J. Elliott and Mark J. Ratain
    Clin Cancer Res October 1 2009 15 (19) 6250-6257; DOI:10.1158/1078-0432.CCR-09-0058

  • Cancer Therapy: Clinical
    Phase II Study of Neoadjuvant Imatinib in Glioblastoma: Evaluation of Clinical and Molecular Effects of the Treatment
    Evangelia Razis, Panayotis Selviaridis, Stephanos Labropoulos, Jeremy L. Norris, Mei-Jun Zhu, David D. Song, Thea Kalebic, Michael Torrens, Anna Kalogera-Fountzila, George Karkavelas, Sofia Karanastasi, Jonathan A. Fletcher and George Fountzilas
    Clin Cancer Res October 1 2009 15 (19) 6258-6266; DOI:10.1158/1078-0432.CCR-08-1867

  • Cancer Therapy: Clinical
    Dendritic Cell Vaccination Combined with CTLA4 Blockade in Patients with Metastatic Melanoma
    Antoni Ribas, Begoña Comin-Anduix, Bartosz Chmielowski, Jason Jalil, Pilar de la Rocha, Tara A. McCannel, Maria Teresa Ochoa, Elizabeth Seja, Arturo Villanueva, Denise K. Oseguera, Bradley R. Straatsma, Alistair J. Cochran, John A. Glaspy, Liu Hui, Francesco M. Marincola, Ena Wang, James S. Economou and Jesus Gomez-Navarro
    Clin Cancer Res October 1 2009 15 (19) 6267-6276; DOI:10.1158/1078-0432.CCR-09-1254

  • Cancer Therapy: Clinical
    A Phase I Study of Sunitinib plus Bevacizumab in Advanced Solid Tumors
    Brian I. Rini, Jorge A. Garcia, Matthew M. Cooney, Paul Elson, Allison Tyler, Kristi Beatty, Joseph Bokar, Tarek Mekhail, R.M. Bukowski, G. Thomas Budd, Pierre Triozzi, Ernest Borden, Percy Ivy, Helen X. Chen, Afshin Dowlati and Robert Dreicer
    Clin Cancer Res October 1 2009 15 (19) 6277-6283; DOI:10.1158/1078-0432.CCR-09-0717

Susceptibility and Prevention

  • Susceptibility and Prevention
    ΔNp63 Overexpression, Alone and in Combination with Other Biomarkers, Predicts the Development of Oral Cancer in Patients with Leukoplakia
    Pierre Saintigny, Adel K. El-Naggar, Vali Papadimitrakopoulou, Hening Ren, You-Hong Fan, Lei Feng, J. Jack Lee, Edward S. Kim, Waun Ki Hong, Scott M. Lippman and Li Mao
    Clin Cancer Res October 1 2009 15 (19) 6284-6291; DOI:10.1158/1078-0432.CCR-09-0498

  • Susceptibility and Prevention
    An miR-502–Binding Site Single-Nucleotide Polymorphism in the 3′-Untranslated Region of the SET8 Gene Is Associated with Early Age of Breast Cancer Onset
    Fengju Song, Hong Zheng, Ben Liu, Sheng Wei, Hongji Dai, Lina Zhang, George A. Calin, Xishan Hao, Qingyi Wei, Wei Zhang and Kexin Chen
    Clin Cancer Res October 1 2009 15 (19) 6292-6300; DOI:10.1158/1078-0432.CCR-09-0826

  • Susceptibility and Prevention
    Recent Natural Selection Identifies a Genetic Variant in a Regulatory Subunit of Protein Phosphatase 2A that Associates with Altered Cancer Risk and Survival
    Lukasz F. Grochola, Alexei Vazquez, Elisabeth E. Bond, Peter Würl, Helge Taubert, Thomas H. Müller, Arnold J. Levine and Gareth L. Bond
    Clin Cancer Res October 1 2009 15 (19) 6301-6308; DOI:10.1158/1078-0432.CCR-09-0797

Back to top
PreviousNext
Clinical Cancer Research: 15 (19)
October 2009
Volume 15, Issue 19
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

Issue Highlights

  • A Comparison of Phase II Study Strategies
  • On Trk—The TrkB Signal Transduction Pathway Is an Increasingly Important Target in Cancer Biology
  • A Phase II Study of SGN-30 in Cutaneous Anaplastic Large Cell Lymphoma and Related Lymphoproliferative Disorders
  • Targeted Radioiodine Therapy of Neuroblastoma Tumors following Systemic Nonviral Delivery of the Sodium Iodide Symporter Gene

Jump to

  • CCR Translations
  • Statistics in Clinical Cancer Research
  • Molecular Pathways
  • Human Cancer Biology
  • Cancer Therapy: Preclinical
  • Imaging, Diagnosis, Prognosis
  • Cancer Therapy: Clinical
  • Susceptibility and Prevention
Advertisement
  • Most Cited
  • Most Read
Loading
  • FLASH-RT Spares Lung Progenitor Cells
  • Toxicity Management Affects Checkpoint Inhibitor Efficacy
  • scRNA-seq Analysis of Gastric Cancer TME
  • PDAC and GATA6 Expression
  • AR Gene Rearrangements in Prostate Cancer
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement